Xu Min, Zhan Yamei, Gao Guohui, Zhu Li, Wu Tong, Xin Guijie
Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China.
Department of Nephrology, The First Hospital of Jilin University, Changchun, China.
Front Nutr. 2024 Aug 16;11:1446694. doi: 10.3389/fnut.2024.1446694. eCollection 2024.
The role of dietary factors in metabolic dysfunction-associated steatotic liver disease (MASLD)-which represents a new definition of liver steatosis and metabolic dysfunction- remains unclear. This study aimed to explore the relationships between dietary indices and MASLD.
We analyzed data from the United States National Health and Nutrition Examination Survey (NHANES) 2017-2020 cycle, including 4,690 participants with complete vibration-controlled transient elastography (VCTE) data. Multivariate logistic regression models adjusted for covariates were used to assess the association between dietary indices, MASLD, and MASLD-associated liver fibrosis (MASLD-LF). Restricted cubic spline (RCS) models and subgroup analyses were also performed.
The Alternative Healthy Eating Index (AHEI), Healthy Eating Index-2020 (HEI-2020), Dietary Approaches to Stop Hypertension Index (DASHI), and Mediterranean Diet Index (MEDI) were found to be negatively associated with MASLD risk, while the Dietary Inflammatory Index (DII) had a positive association. The highest quartile of MEDI was linked to a 44% reduction in MASLD risk [Q1 vs. Q4 odds ratio (OR): 0.56; 95% confidence interval (CI): 0.34-0.94, P for trend: 0.012]. DASHI was uniquely associated with a reduced risk of MASLD-LF (continuous OR: 0.79; 95% CI: 0.64-0.97; for trend: 0.003). Our RCS curves indicated a nonlinear association with DASHI-MASLD (-overall: 0.0001, p-nonlinear: 0.0066). Subgroup analyses showed robust associations among the non-Hispanic White and highly educated populations.
Specific dietary patterns were associated with reduced risks of MASLD and MASLD-LF. The DASHI, in particular, showed a significant protective effect against MASLD-LF. These findings suggest potential dietary interventions for managing MASLD and MASLD-LF, although large-scale randomized controlled trials are warranted to validate these findings.
饮食因素在代谢功能障碍相关脂肪性肝病(MASLD)中的作用仍不明确,MASLD是肝脂肪变性和代谢功能障碍的新定义。本研究旨在探讨饮食指数与MASLD之间的关系。
我们分析了美国国家健康与营养检查调查(NHANES)2017 - 2020周期的数据,包括4690名有完整振动控制瞬时弹性成像(VCTE)数据的参与者。使用针对协变量进行调整的多变量逻辑回归模型来评估饮食指数、MASLD和MASLD相关肝纤维化(MASLD - LF)之间的关联。还进行了限制立方样条(RCS)模型和亚组分析。
发现替代健康饮食指数(AHEI)、2020年健康饮食指数(HEI - 2020)、终止高血压饮食方法指数(DASHI)和地中海饮食指数(MEDI)与MASLD风险呈负相关,而饮食炎症指数(DII)呈正相关。MEDI的最高四分位数与MASLD风险降低44%相关[第一四分位数(Q1)与第四四分位数比值比(OR):0.56;95%置信区间(CI):0.34 - 0.94,趋势P值:0.012]。DASHI与MASLD - LF风险降低独特相关(连续OR:0.79;95% CI:0.64 - 0.97;趋势P值:0.003)。我们的RCS曲线表明DASHI与MASLD之间存在非线性关联(总体P值:0.0001,非线性P值:0.0066)。亚组分析显示在非西班牙裔白人和高学历人群中存在显著关联。
特定的饮食模式与MASLD和MASLD - LF风险降低相关。特别是DASHI对MASLD - LF显示出显著的保护作用。这些发现提示了针对管理MASLD和MASLD - LF的潜在饮食干预措施,尽管需要大规模随机对照试验来验证这些发现。